Arcturus Therapeutics Holdings Inc
Research Arcturus Therapeutics Holdings Inc (ARCT) on Bullrun: market cap USD 193.85M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerARCT
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 193.85M
- Financial periodFY2025
- RevenueUSD 82.03M
- Revenue growth-46.1%
- Net income-USD 65.78M
- Free cash flow-USD 74.50M
Valuation Snapshot
latest market cap is USD 193.85M.
About Arcturus Therapeutics Holdings Inc
Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system. The company also develops ARCT-032 (LUNAR-CF), an mRNA therapeutic candidate for cystic fibrosis that is in Phase 2 clinical development;
Frequently asked questions
What is Arcturus Therapeutics Holdings Inc's market cap?
Arcturus Therapeutics Holdings Inc's market capitalization is USD 193.85M.
What does Arcturus Therapeutics Holdings Inc do?
Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system.